Author:
Meulendijks Didier,Beerepoot Laurens V.,Boot Henk,de Groot Jan Willem B.,Los Maartje,Boers James E.,Vanhoutvin Steven A. L. W.,Polee Marco B.,Beeker Aart,Portielje Johanna E. A.,de Jong Robert S.,Goey Swan H.,Kuiper Maria,Sikorska Karolina,Beijnen Jos H.,Tesselaar Margot E.,Schellens Jan H. M.,Cats Annemieke
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference43 articles.
1. Wagner AD, Unverzagt S, Grothe W, et al. (2010) Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev 3:CD004064. doi: 10.1002/14651858.CD004064.pub3
2. Van Cutsem E, Moiseyenko VM, Tjulandin S, et al. (2006) Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 24:4991–4997. doi: 10.1200/JCO.2006.06.8429
3. Wang J, Xu R, Li J, et al. (2015) Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer. Gastric Cancer. doi: 10.1007/s10120-015-0457-4
4. Amarantidis K, Xenidis N, Chelis L, et al. (2011) Docetaxel plus oxaliplatin in combination with capecitabine as first-line treatment for advanced gastric cancer. Oncology 80:359–365. doi: 10.1159/000330199
5. Di Lauro L, Vici P, Belli F, et al. (2014) Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer. Gastric Cancer 17:718–724. doi: 10.1007/s10120-013-0321-3
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献